PL2366703T3 - Postać polimorficzna pochodnej 2-amino-(nitroarylo)-tiazolu - Google Patents

Postać polimorficzna pochodnej 2-amino-(nitroarylo)-tiazolu

Info

Publication number: PL2366703T3
Authority: PL; Poland
Prior art keywords: nitroaryl; amino; polymorph form; thiazole derivative; thiazole
Prior art date: 2007-02-13

Application number

PL11170200T

Other languages

English (en)

Inventor

Alain Moussy

Philippe Reginault

François Bellamy

Anne Lermet

Original Assignee

Ab Science

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2007-02-13

Filing date

2008-02-13

Publication date

2015-02-27

2008-02-13 Application filed by Ab Science filed Critical Ab Science

2015-02-27 Publication of PL2366703T3 publication Critical patent/PL2366703T3/pl

Links

GOJUJUVQIVIZAV-UHFFFAOYSA-N 2-amino-4,6-dichloropyrimidine-5-carbaldehyde Chemical group NC1=NC(Cl)=C(C=O)C(Cl)=N1 GOJUJUVQIVIZAV-UHFFFAOYSA-N 0.000 title 1
125000004999 nitroaryl group Chemical group 0.000 title 1
150000007979 thiazole derivatives Chemical class 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
General Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Immunology (AREA)
Rheumatology (AREA)
Diabetes (AREA)
Physical Education & Sports Medicine (AREA)
Oncology (AREA)
Hematology (AREA)
Orthopedic Medicine & Surgery (AREA)
Obesity (AREA)
Emergency Medicine (AREA)
Communicable Diseases (AREA)
Transplantation (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Pain & Pain Management (AREA)
Endocrinology (AREA)
Neurosurgery (AREA)
Pulmonology (AREA)
Urology & Nephrology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Thiazole And Isothizaole Compounds (AREA)
Catalysts (AREA)
Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

PL11170200T 2007-02-13 2008-02-13 Postać polimorficzna pochodnej 2-amino-(nitroarylo)-tiazolu PL2366703T3 (pl)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US88958707P	2007-02-13	2007-02-13
EP08708929A EP2118099B1 (en)	2007-02-13	2008-02-13	Process for the synthesis of 2-aminothiazole compounds as kinase inhibitors
EP11170200.7A EP2366703B1 (en)	2007-02-13	2008-02-13	Polymorph form of 2-amino (nitroaryl) thiazole derivative

Publications (1)

Publication Number	Publication Date
PL2366703T3 true PL2366703T3 (pl)	2015-02-27

Family

ID=39332208

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
PL11170200T PL2366703T3 (pl)	2007-02-13	2008-02-13	Postać polimorficzna pochodnej 2-amino-(nitroarylo)-tiazolu
PL08708929T PL2118099T3 (pl)	2007-02-13	2008-02-13	Proces syntezy związków 2-aminotiazolu jako inhibitorów kinazy

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
PL08708929T PL2118099T3 (pl)	2007-02-13	2008-02-13	Proces syntezy związków 2-aminotiazolu jako inhibitorów kinazy

Country Status (23)

Country	Link
US (3)	US8153792B2 (pl)
EP (2)	EP2366703B1 (pl)
JP (2)	JP5568312B2 (pl)
KR (1)	KR20090110851A (pl)
CN (2)	CN103342701B (pl)
AR (1)	AR065337A1 (pl)
AT (1)	ATE515506T1 (pl)
AU (1)	AU2008214679A1 (pl)
BR (1)	BRPI0807626B1 (pl)
CA (2)	CA2677586C (pl)
ES (2)	ES2369617T3 (pl)
HR (2)	HRP20110709T1 (pl)
IL (1)	IL200320A0 (pl)
MA (1)	MA31180B1 (pl)
MX (1)	MX2009008665A (pl)
NZ (1)	NZ578944A (pl)
PL (2)	PL2366703T3 (pl)
RU (2)	RU2456285C2 (pl)
SI (2)	SI2366703T1 (pl)
TN (1)	TN2009000342A1 (pl)
TW (1)	TWI406862B (pl)
WO (1)	WO2008098949A2 (pl)
ZA (1)	ZA200905981B (pl)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
MXPA05001277A (es)	2002-08-02	2005-10-06	Ab Science	2-(3-aminoaril)amino-4-aril-tiazoles y su uso como inhibidores del c-kit.
US8450302B2 (en)	2002-08-02	2013-05-28	Ab Science	2-(3-aminoaryl) amino-4-aryl-thiazoles and their use as c-kit inhibitors
US20120302577A1 (en)	2010-01-28	2012-11-29	Ab Science	Treatment of gist with masitinib
TW201130830A (en)	2010-02-01	2011-09-16	Ab Science	Combined treatment of pancreatic cancer with gemcitabine and masitinib
AR080380A1 (es)	2010-03-09	2012-04-04	Ab Science	Tratamiento de la demencia tipo alzheimer con masitinib
TW201204360A (en)	2010-04-20	2012-02-01	Ab Science	Treatment of multiple sclerosis with MASITINIB
WO2011151372A1 (en)	2010-06-02	2011-12-08	Ab Science	Treatment of rheumatoid arthritis with masitinib
US10045978B2 (en)	2010-11-05	2018-08-14	Ab Science	Treatment of mastocytosis with masitinib
WO2012059526A1 (en)	2010-11-05	2012-05-10	Ab Science	Treatment of mastocytosis with masitinib
WO2012104402A1 (en) *	2011-02-04	2012-08-09	Ab Science	Treatment of severe persitent asthma with masitinib
US20140051662A1 (en)	2011-04-08	2014-02-20	Ab Science	Treatment of multiple myeloma with masitinib
AU2013326463B2 (en)	2012-10-04	2018-01-18	Ab Science	Use of masitinib for treatment of cancer in patient subpopulations identified using predictor factors
TW201605449A (zh)	2013-12-02	2016-02-16	Ａｂ化學公司	馬賽替尼治療結腸直腸癌的用途
EP2886543A1 (en)	2013-12-18	2015-06-24	Sandoz Ag	Crystalline form of mastinib mesylate
WO2015185958A1 (en)	2014-06-02	2015-12-10	Ab Science	Use of an inhibitor of kinase activity, particularly masitinib, for treatment of prostate cancer
CN105585556A (zh) *	2014-11-13	2016-05-18	连云港杰瑞药业有限公司	一种伊马替尼的合成方法
WO2017016512A1 (zh) *	2015-07-29	2017-02-02	苏州晶云药物科技有限公司	马赛替尼甲磺酸盐的新晶型及其制备方法
CA3000894A1 (en)	2015-10-05	2017-04-13	Ab Science	Treatment of severe systemic mastocytosis with masitinib
EA038531B1 (ru)	2016-03-25	2021-09-10	Аб Сьянс	Способ лечения амиотрофного латерального склероза, применение фармацевтической композиции, содержащей мазитиниб
WO2018177854A1 (en)	2017-03-31	2018-10-04	Sandoz Ag	Crystalline form of masitinib
US10696638B2 (en)	2017-12-26	2020-06-30	Industrial Technology Research Institute	Compounds for inhibiting AGC kinase and pharmaceutical compositions comprising the same
EP4061371B1 (en)	2019-11-22	2025-02-19	AB Science	Masitinib for the treatment of sickle cell disease
EP3831384A1 (en)	2019-12-02	2021-06-09	AB Science	Use of masitinib for the treatment of eosinophilic asthma
AU2021223710A1 (en)	2020-02-20	2022-07-28	Ab Science	Masitinib for the treatment of a multiple sclerosis patient subpopulation
WO2021205029A1 (en)	2020-04-10	2021-10-14	Ab Science	Use of masitinib for the treatment of coronavirus disease 2019 (covid-19)
US20240058328A1 (en)	2020-12-16	2024-02-22	Ab Science	Masitinib for the treatment of alzheimer's disease
ES2963706T3 (es)	2021-05-17	2024-04-01	Ab Science	Masitinib para el tratamiento del cáncer de próstata resistente a la castración
CN115850258B (zh) *	2022-12-27	2024-09-24	东北林业大学	一种马赛替尼的合成方法
WO2025264860A2 (en)	2024-06-18	2025-12-26	Yale University	Methods of treating post-covid airway disease

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3299087A (en) *	1961-04-24	1967-01-17	Geigy Chem Corp	Nu, nu'-bis-(thiazolyl)-phenylenediamines
US5932576A (en) *	1997-05-22	1999-08-03	G. D. Searle & Company	3(5)-heteroaryl substituted pyrazoles as p38 kinase inhibitors
CO4940418A1 (es) *	1997-07-18	2000-07-24	Novartis Ag	Modificacion de cristal de un derivado de n-fenil-2- pirimidinamina, procesos para su fabricacion y su uso
GB9718913D0 (en) *	1997-09-05	1997-11-12	Glaxo Group Ltd	Substituted oxindole derivatives
CN1158269C (zh) *	1997-10-27	2004-07-21	阿古龙制药公司	作为cdk抑制剂的取代的4-氨基-噻唑-2-基化合物
US6114365A (en) *	1999-08-12	2000-09-05	Pharmacia & Upjohn S.P.A.	Arylmethyl-carbonylamino-thiazole derivatives, process for their preparation, and their use as antitumor agents
MXPA02002559A (es) *	1999-09-10	2002-07-30	Merck & Co Inc	Inhibidores de tirosina cinasa.
US20030091974A1 (en)	2001-06-29	2003-05-15	Alain Moussy	Method for screening compounds capable of depleting mast cells
JP2005503361A (ja)	2001-06-29	2005-02-03	アブサイエンス	肥満細胞症治療のための強力で選択的かつ非毒性のｃ−ｋｉｔ阻害剤の使用
WO2003003006A2 (en)	2001-06-29	2003-01-09	Ab Science	New potent, selective and non toxic c-kit inhibitors
DE60227709D1 (de)	2001-06-29	2008-08-28	Ab Science	Die verwendung von c-kithemmern zur behandlung von autoimmunerkrankungen
PT1401416E (pt)	2001-06-29	2007-02-28	Ab Science	Utilização de inibidores de c-kit para tratar doenças inflamatórias intestinais (dii)
WO2003002107A2 (en)	2001-06-29	2003-01-09	Ab Science	Use of tyrosine kinase inhibitors for treating multiple sclerosis (ms)
ES2274993T3 (es)	2001-06-29	2007-06-01	Ab Science	Utilizacion de inhibidores de tirosina cinasa para el tratamiento de enfermedades alergicas.
JP2004530730A (ja)	2001-06-29	2004-10-07	アブサイエンス	腫瘍の血管新生を治療するための強力で選択的かつ非毒性のｃ−ｋｉｔ阻害剤の使用法
WO2003002105A2 (en)	2001-06-29	2003-01-09	Ab Science	Use of tyrosine kinase inhibitors for treating bone loss
ATE330608T1 (de)	2001-06-29	2006-07-15	Ab Science	Die verwendung von n-phenyl-2-pyrimidine-amine derivaten zur behandlung von entzündlichen erkrankungen
EP1461032B1 (en)	2001-09-20	2008-07-16	AB Science	Use of c-kit inhibitors for promoting hair growth
JP2005511596A (ja)	2001-09-20	2005-04-28	アブサイエンス	ヒトの皮膚を白くし、且つメラノサイト機能不全関連疾病を治療するためのチロシンキナーゼ阻害剤の使用方法
DE60225590T2 (de)	2001-09-20	2008-09-25	Ab Science	C-kithemmer zur behandlung von bakteriellen infektionen
PT1478380E (pt)	2002-02-27	2006-12-29	Ab Science	Utilização de inibidores de tirosina-cinases para tratar doenças do snc
ATE408407T1 (de)	2002-02-27	2008-10-15	Ab Science	Verwendung von tyrosinkinase-hemmern zur behandlung von erkrankungen im zusammenhang mit substanzgebrauch
CA2486530A1 (en) *	2002-05-29	2003-12-11	Amgen Inc.	2-oxo-1,3,4-trihydroquinazolinyl derivatives for the treatment of cell proliferation-related disorders
MXPA05001277A (es)	2002-08-02	2005-10-06	Ab Science	2-(3-aminoaril)amino-4-aril-tiazoles y su uso como inhibidores del c-kit.
SE0202462D0 (sv) *	2002-08-14	2002-08-14	Astrazeneca Ab	Novel use
WO2004072068A1 (en) *	2003-02-10	2004-08-26	Amgen Inc.	Vanilloid receptor ligands and their use in treatments
ATE393243T1 (de)	2003-02-27	2008-05-15	Ab Science	Diagnostisches verfahren der mastozytose
FR2854158B1 (fr) *	2003-04-25	2006-11-17	Sanofi Synthelabo	Derives de 2-acylamino-4-phenylethiazole, leur preparation et leur application en therapeutique
AU2004260689B8 (en) *	2003-07-29	2008-05-15	Irm Llc	Compounds and compositions as protein kinase inhibitors
DE602004013792D1 (de)	2003-08-15	2008-06-26	Ab Science	Verwendung von c-kit-inhibitoren für die behandlung von typ-2-diabetes
US7363881B2 (en)	2003-11-06	2008-04-29	Nova-Tech Engineering, Inc.	Beak treatment with tongue protection
WO2005063709A1 (ja)	2003-12-25	2005-07-14	Nippon Shinyaku Co., Ltd.	アミド誘導体及び医薬
US7650848B2 (en) *	2004-02-17	2010-01-26	University Of Florida Research Foundation, Inc.	Surface topographies for non-toxic bioadhesion control
WO2005115385A1 (en) *	2004-05-24	2005-12-08	Ab Science	Use of c-kit inhibitors for treating acne
TW200702876A (en) *	2005-07-04	2007-01-16	Avermedia Tech Inc	Projector device capable of sychronously encoding audio and video to become AV sychronous paly file

2008
- 2008-02-13 HR HR20110709T patent/HRP20110709T1/hr unknown
- 2008-02-13 JP JP2009549405A patent/JP5568312B2/ja not_active Expired - Fee Related
- 2008-02-13 PL PL11170200T patent/PL2366703T3/pl unknown
- 2008-02-13 CA CA2677586A patent/CA2677586C/en active Active
- 2008-02-13 AU AU2008214679A patent/AU2008214679A1/en not_active Abandoned
- 2008-02-13 NZ NZ578944A patent/NZ578944A/en unknown
- 2008-02-13 BR BRPI0807626-0A patent/BRPI0807626B1/pt not_active IP Right Cessation
- 2008-02-13 EP EP11170200.7A patent/EP2366703B1/en active Active
- 2008-02-13 WO PCT/EP2008/051704 patent/WO2008098949A2/en not_active Ceased
- 2008-02-13 PL PL08708929T patent/PL2118099T3/pl unknown
- 2008-02-13 MX MX2009008665A patent/MX2009008665A/es active IP Right Grant
- 2008-02-13 AT AT08708929T patent/ATE515506T1/de not_active IP Right Cessation
- 2008-02-13 ES ES08708929T patent/ES2369617T3/es active Active
- 2008-02-13 SI SI200831294T patent/SI2366703T1/sl unknown
- 2008-02-13 KR KR1020097016822A patent/KR20090110851A/ko not_active Withdrawn
- 2008-02-13 EP EP08708929A patent/EP2118099B1/en active Active
- 2008-02-13 CA CA2970628A patent/CA2970628C/en active Active
- 2008-02-13 CN CN201310141370.2A patent/CN103342701B/zh active Active
- 2008-02-13 SI SI200830399T patent/SI2118099T1/sl unknown
- 2008-02-13 RU RU2009132186/04A patent/RU2456285C2/ru active
- 2008-02-13 ES ES11170200.7T patent/ES2522169T3/es active Active
- 2008-02-13 US US12/526,827 patent/US8153792B2/en active Active
- 2008-02-13 TW TW097105021A patent/TWI406862B/zh not_active IP Right Cessation
- 2008-02-13 CN CN2008800049044A patent/CN101657446B/zh active Active
- 2008-02-13 AR ARP080100620A patent/AR065337A1/es active IP Right Grant
2009
- 2009-08-10 IL IL200320A patent/IL200320A0/en unknown
- 2009-08-11 MA MA32161A patent/MA31180B1/fr unknown
- 2009-08-11 TN TNP2009000342A patent/TN2009000342A1/fr unknown
- 2009-08-28 ZA ZA2009/05981A patent/ZA200905981B/en unknown
2012
- 2012-03-08 US US13/415,249 patent/US8492545B2/en active Active
- 2012-04-12 RU RU2012114234/04A patent/RU2491286C1/ru active
2013
- 2013-05-10 US US13/891,639 patent/US8940894B2/en active Active
- 2013-05-30 JP JP2013113789A patent/JP5784073B2/ja active Active
2014
- 2014-10-15 HR HRP20140986AT patent/HRP20140986T1/hr unknown

Also Published As

Publication number	Publication date
NZ578944A (en)	2011-03-31
RU2456285C2 (ru)	2012-07-20
CN101657446B (zh)	2013-05-15
CN101657446A (zh)	2010-02-24
ZA200905981B (en)	2010-11-24
ATE515506T1 (de)	2011-07-15
SI2366703T1 (sl)	2014-10-30
ES2522169T3 (es)	2014-11-13
EP2366703B1 (en)	2014-07-30
RU2491286C1 (ru)	2013-08-27
WO2008098949A2 (en)	2008-08-21
TWI406862B (zh)	2013-09-01
US8492545B2 (en)	2013-07-23
ES2369617T3 (es)	2011-12-02
CA2677586C (en)	2017-07-25
HRP20110709T1 (hr)	2011-11-30
EP2118099B1 (en)	2011-07-06
JP5784073B2 (ja)	2015-09-24
AU2008214679A1 (en)	2008-08-21
CA2970628A1 (en)	2008-08-21
US8153792B2 (en)	2012-04-10
BRPI0807626A2 (pt)	2014-11-25
RU2009132186A (ru)	2011-03-20
JP5568312B2 (ja)	2014-08-06
EP2366703A1 (en)	2011-09-21
EP2118099A2 (en)	2009-11-18
WO2008098949A3 (en)	2008-10-02
SI2118099T1 (sl)	2011-11-30
CA2970628C (en)	2019-08-27
BRPI0807626B1 (pt)	2022-03-03
TN2009000342A1 (en)	2010-12-31
JP2013177437A (ja)	2013-09-09
US8940894B2 (en)	2015-01-27
CN103342701A (zh)	2013-10-09
KR20090110851A (ko)	2009-10-22
TW200848419A (en)	2008-12-16
HRP20140986T1 (hr)	2014-11-21
PL2118099T3 (pl)	2011-12-30
MX2009008665A (es)	2009-08-21
AR065337A1 (es)	2009-06-03
US20130289045A1 (en)	2013-10-31
CN103342701B (zh)	2016-09-21
CA2677586A1 (en)	2008-08-21
JP2010518141A (ja)	2010-05-27
IL200320A0 (en)	2010-04-29
MA31180B1 (fr)	2010-02-01
US20100121063A1 (en)	2010-05-13
US20120196871A1 (en)	2012-08-02

Publication	Publication Date	Title
SI2366703T1 (sl)	2014-10-30	Polimorfna oblika 2-amino (nitroaril) tiazolnega derivata
PL2614825T3 (pl)	2017-08-31	Sposób wytwarzania pochodnych tiazolu
GB0812031D0 (en)	2008-08-06	Thiazole derivatives
IL206286A0 (en)	2010-12-30	Thiazole derivatives used as pi 3 kinase inhibitors
IL204563A0 (en)	2010-11-30	Thiazole derivatives
GB0722216D0 (en)	2007-12-27	Use of crth2 antagonist compounds
GB0722203D0 (en)	2007-12-19	Use of CRTH2 antagonist compounds
IL205751A0 (en)	2010-11-30	Aminothiazole derivatives
ZA200906050B (en)	2010-05-26	Process for the preparation of a benzimidazole derivative
IL198847A0 (en)	2010-02-17	New process for the preparation of 2-imino-thiazolidin-4-one derivatives
IL195007A0 (en)	2009-08-03	Thiazole derivatives
IL199840A0 (en)	2010-04-15	Combinations of beta- 2 -adrenoceptor agonistic benzothiazolone
ZA200906712B (en)	2011-02-23	Fluorinated derivatives of deferiprone
EP2242493A4 (en)	2011-09-07	Gefitinib DERIVATIVES
SI2220152T1 (sl)	2013-02-28	Postopek za pripravo sestavka premreĹľevalnega sredstva
SI2121553T1 (sl)	2012-11-30	Postopek za pripravo terapevtsko uporabnih trifenilbutenskih derivatov
HUP0800766A2 (en)	2010-11-29	Process for the preparation of piperazine derivatives
EP2195309A4 (en)	2013-04-24	SALT POLYMORPHS OF THE ESOMEPRAZOLE
PL2220060T3 (pl)	2017-03-31	Pochodne tetrahydrobenzotiazolu
IL237789A0 (en)	2015-05-31	Methods for using thiazole history
IL192988A0 (en)	2009-02-11	Heterobicyclic amide derivatives
IL205082A0 (en)	2010-11-30	Process for the preparation of tetranorlabdane derivatives
GB0624963D0 (en)	2007-01-24	Derivatives of 188-Glycyrrhetinic Acid
FI20070134A0 (fi)	2007-02-15	Menetelmä pelkistysainekoostumuksen valmistamiseksi
SI2170906T1 (sl)	2013-07-31	Zliti derivati tiazola, kot inhibitorji kinaze